<DOC>
	<DOCNO>NCT01701193</DOCNO>
	<brief_summary>The purpose study determine whether amino acid effective treatment prevent abdominal/pelvic scar tissue .</brief_summary>
	<brief_title>A Phase I Study For Reduction Scar Tissue Adult Females Undergoing Surgery Ectopic Pregnancy</brief_title>
	<detailed_description />
	<mesh_term>Tissue Adhesions</mesh_term>
	<mesh_term>Pregnancy , Ectopic</mesh_term>
	<criteria>Subjects female Subjects 18 year age old time consent Subjects BMI 17 35 Subjects subject 's legal representative must sign informed consent form Subjects preoperative diagnosis ectopic pregnancy ultrasonographic confirmation absence intrauterine ectopic pregnancy Subjects whose BMI outside range 17 35 Subjects participate another clinical trial drug device Subjects participate clinical trial drug device within 30 day prior study Subjects suspect diagnosed coexist intrauterine pregnancy Subjects suspect intraabdominal infection Subjects immunocompromised Subjects diagnose cancer Subjects treat hemostatic agent ( e.g . fibrin sealant , collagen , oxidize cellulose ) Subjects treated adhesion prevention agent AntiAdhesion Product ( APP ) ( e.g . Intergel® Adhesion Prevention Solution , Seprafilm® Membrane ) Subjects take antiepileptic medication Subjects treat Methotrexate chemotherapeutic agent</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>